Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NURO | US
-0.06
-1.47%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
4.14
4.16
4.16
4.09
NeuroMetrix Inc. a commercial stage neurotechnology company engages in designing building and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States Europe Japan China the Middle East and Mexico. Its primary marketed products include DPNCheck a nerve conduction test that is used to evaluate peripheral neuropathies such as diabetic peripheral neuropathy; Quell a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations endocrinologists podiatrists and primary care physicians; occupational health primary care internal medicine orthopedic and hand surgeons; and pain medicine physicians neurologists physical medicine and rehabilitation physicians and neurosurgeons. NeuroMetrix Inc. was incorporated in 1996 and is headquartered in Woburn Massachusetts.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.2%1 month
44.8%3 months
62.5%6 months
59.4%-
-
0.46
0.01
0.01
1.46
0.24
-0.01
-8.24M
8.38M
8.38M
-
-237.75
-
-53.50
-40.99
0.70
0.67
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.62
Range1M
0.64
Range3M
1.61
Rel. volume
0.08
Price X volume
6.69K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Nexalin Technology Inc. | NXL | Medical Devices | 0.6579 | 6.96M | 5.45% | n/a | 0.00% |
INBS | INBS | Medical Devices | 1.59 | 6.76M | 1.92% | n/a | 10.46% |
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6434 | 4.29M | -11.63% | n/a | 65.94% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Common Stock | VERO | Medical Devices | 0.4488 | 3.26M | -12.00% | n/a | 1351.51% |
Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.78 | 3.24M | -6.32% | n/a | 38.66% |
INVO Bioscience Inc | INVO | Medical Devices | 0.7 | 2.73M | 3.55% | 1.03 | 394.32% |
ThermoGenesis Holdings Inc | THMO | Medical Devices | 0.16 | 2.54M | 1.20% | n/a | 776.10% |
NUWE | NUWE | Medical Devices | 1.32 | 2.46M | -10.81% | n/a | -9.57% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.46 | 7.69 | Cheaper |
Ent. to Revenue | 0.24 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 0.46 | 6.11 | Cheaper |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 62.54 | 55.82 | Par |
Debt to Equity | 0.01 | 0.86 | Cheaper |
Debt to Assets | 0.01 | 0.26 | Cheaper |
Market Cap | 8.38M | 9.95B | Emerging |